February 01, 2025

Standing for Those With Intellectual/ Developmental Disabilities

It is time for people with intellectual/developmental disabilities (IDD), their families, the village that supports them, and the healthcare professionals that are responsible for their well-being to grab their pitchforks and storm the castle to end the purposeful exclusion by our government to designate them a medically underserved population (MUP).

Compendium

January 28, 2025

New resources for National Children’s Dental Health Month available

National Children's Dental Health Month promotes the benefits of good oral health to children, their caregivers, teachers and many others.

ADA News

January 21, 2025

AAP Updates Child Abuse Fracture Evaluation Protocol

The report provides extensive guidance on differentiating between abusive and non-abusive fractures while acknowledging diagnostic challenges.

Conexiant

January 16, 2025

New XLH Guidelines Shift Primary Therapy to Burosumab

"Burosumab treatment normalized ALP serum levels in about 80% of both pediatric and adolescent cohorts, suggesting a substantial improvement of rickets in these patients," report authors of comprehensive new evidence-based recommendations for X-linked hypophosphatemia management.

Conexiant

September 04, 2023

Transforming Toast with Tech: Modernizing Ketogenic Therapy

For centuries, dietary manipulation, including fasting, has been used for the treatment of epilepsy. In the early 1920s, physicians at Mayo Clinic discovered that a low carbohydrate diet provided similar effects to fasting and coined the term “ketogenic diet,” which is still in use today. Ketogenic therapy (KT) is a diet with high fat, low carbohydrate and adequate protein intake. The KT program at the Barrow Neurological Institute at Phoenix Children’s is a robust clinical program staffed by experienced dietitians, psychologists, pharmacists and epileptologists

Phoenix Children's Medical Connection

October 29, 2024

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Conexiant

April 21, 2023

Benevis Spotlights Diversity in Dentistry and Dental Health Disparities this Minority Health Month

Benevis Spotlights Diversity in Dentistry

Inside Dentistry

June 15, 2023

Eisenmenger Syndrome & Pulmonary Hypertension in Congenital Heart Disease

Dr. Alexander Ellis describes the origin of Eisenmenger syndrome and disease specific therapies for congenital heart patients.

Sentara

September 28, 2023

Screening Clinical Trial Points the Way to Treatments Informed by Genomic Sequencing

A screening clinical trial underway at Roswell Park Comprehensive Cancer Center and other centers across the U.S. will take the next step toward determining the effectiveness of cancer treatments informed by genomic sequencing of the tumor.

Roswell Park Comprehensive Cancer Center